8-K: Berry Global Reports Solid Q3 2024 Results, Announces Progress on Portfolio Optimization

Berry Global announced its third quarter 2024 financial results, highlighting a 2% organic volume growth and progress on the spin-off and merger of its Health, Hygiene & Specialties segment.

Summary

• Berry Global reported net sales of $3.2 billion for the third quarter of 2024, a 2% decrease compared to the same period last year, primarily due to lower resin prices.
• The company achieved a 2% organic volume growth across all four operating segments.
• Operating income increased by 13% year-over-year to $303 million, driven by volume growth and cost reduction initiatives.
• Adjusted earnings per share were $2.18, a 16% increase compared to the prior year.
• Operating EBITDA reached $546 million, a 5% increase year-over-year.
• Berry is on track with the spin-off and merger of its Health, Hygiene & Specialties (HH&S) segment with Glatfelter Corporation, with the transaction valued at $3.6 billion.
• The company expects adjusted EPS of $7.60 and free cash flow between $800-$900 million for fiscal year 2024.
• Berry has repurchased 2.0 million shares for $117 million in the first three quarters of fiscal 2024 and has $324 million remaining authorized for share repurchases.
• A quarterly cash dividend of $0.275 per share was declared, payable on September 17, 2024.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong earnings growth, progress on strategic initiatives, and a commitment to shareholder returns. While there are some challenges, the overall tone is optimistic and suggests a well-managed company.

Positives

• Berry achieved a 2% organic volume growth across all four operating segments, indicating strong demand for its products.
• Operating income increased by 13% due to volume growth and cost reduction initiatives.
• Adjusted earnings per share increased by 16%, demonstrating improved profitability.
• The company is making progress on its portfolio optimization strategy with the HH&S spin-off and merger on track.
• Berry is committed to returning capital to shareholders through dividends and share repurchases.
• The company expects to be within its leverage target of 2.5x 3.5x by the end of fiscal 2024.
• Berry's operating EBITDA margins were 110 basis points higher than the previous year.

Negatives

• Net sales decreased by 2% due to the pass-through of lower resin prices.
• Consumer Packaging International net sales decreased by 7% due to lower resin prices and divestitures.
• Flexibles net sales decreased by 2% due to lower selling prices.
• Health, Hygiene & Specialties net sales decreased by 2% due to lower selling prices.

Risks

• The company faces risks associated with its substantial indebtedness and debt service.
• Fluctuations in resin and other raw material prices could impact profitability.
• There are risks related to the successful completion of the HH&S spin-off and merger with Glatfelter.
• The company is exposed to risks related to international business, including currency exchange rate fluctuations.
• Berry faces risks related to disruptions in the global economy, supply chain issues, and financial market volatility.
• There are risks related to potential litigation brought in connection with the proposed transaction.
• The company faces risks related to the failure of, inadequacy of, or attacks on its information technology systems and infrastructure.

Future Outlook

Berry expects business momentum to continue, including low-single digit volume growth in the fiscal fourth quarter and exiting fiscal 2024 at or below its 3.5x leverage target. The company anticipates adjusted EPS of $7.60 and free cash flow of $800-$900 million for fiscal year 2024.

Management Comments

• Kevin Kwilinski, Berry's CEO, stated that the company's strong financial results were consistent with expectations and that the teams executed very well.
• Kwilinski emphasized the company's outstanding performance in achieving volume and earnings growth, as well as progress in reducing leverage and optimizing the portfolio.
• Kwilinski mentioned that the company is focusing on optimizing its portfolio, implementing lean transformation, and driving growth through commercial excellence.
• Curt Begle, President of Berry's Health Hygiene & Specialties Division, who will lead Magnera as CEO, said that Magnera's purpose is to better the world with new possibilities made real.

Industry Context

The announcement reflects a trend in the packaging industry towards portfolio optimization and focusing on core businesses. The spin-off and merger of the HH&S segment is a strategic move to create a pure-play packaging company and a separate leader in specialty materials. This is in line with other companies seeking to streamline operations and enhance shareholder value through strategic transactions.

Comparison to Industry Standards

• Berry's 2% organic volume growth is a positive sign, indicating solid demand in a competitive market. Comparatively, other packaging companies like Amcor and Sealed Air have also been focusing on volume growth and cost management.
• The 16% increase in adjusted EPS is a strong performance, suggesting effective cost control and operational efficiency. This compares favorably to some peers who have faced challenges with rising input costs.
• The planned spin-off and merger of the HH&S segment is a significant strategic move, similar to other companies that have divested non-core assets to focus on their primary businesses. For example, DuPont's spin-off of its specialty chemicals business is a comparable strategic move.
• Berry's leverage target of 2.5x 3.5x is in line with industry standards for companies with significant debt. Many packaging companies aim to maintain a similar leverage ratio to balance growth and financial stability.

Management Changes

Stakeholder Impact

• Shareholders will benefit from the company's commitment to returning capital through dividends and share repurchases.
• Employees may experience changes due to the spin-off and merger of the HH&S segment.
• Customers will continue to receive innovative packaging solutions from Berry.
• Suppliers will continue to engage with Berry as a key partner.
• Creditors will be impacted by the company's debt reduction efforts.

Next Steps

• The company will continue to focus on optimizing its portfolio to accelerate growth and deleveraging.
• Berry will implement its lean transformation initiatives.
• The company will drive growth by enhancing its commercial excellence.
• Berry will continue to work towards completing the spin-off and merger of its HH&S segment with Glatfelter.
• The company will continue to repurchase shares and pay dividends, subject to market conditions.
• Berry will host a conference call to discuss the third quarter results.

Key Dates

Keywords

packaging, financial results, organic volume growth, EBITDA, earnings per share, portfolio optimization, spin-off, merger, Glatfelter, share repurchase, dividend, debt reduction, leverage